Evidence map›Paper›PMID 21420985›Full record

ReviewNeuropharmacology2011

Insulin signaling and addiction.

Lynette C Daws, Malcolm J Avison, Sabrina D Robertson, Kevin D Niswender, Aurelio Galli, Christine Saunders

Abstract readReview
In one paragraph

Review in Neuropharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Lynette C DawsDepartment of Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Malcolm J Avison
Sabrina D Robertson
Kevin D Niswender
Aurelio Galli
Christine Saunders
Vanderbilt University · USNational Institute of Environmental Health Sciences · USThe University of Texas Health Science Center at San Antonio · US

Funding

Insulin Regulation of Monoamine Signaling: Pathway to ObesityR01DK085712 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GALLI, AURELIO, NISWENDER, KEVIN D · 2009 to 2013
$5.0M
Molecular Mechanisms of Stimulant AbuseR01DA014684 · NIDA · VANDERBILT UNIVERSITY · PI DAWS, LYNETTE C, GALLI, AURELIO · 2001 to 2010
$2.4M
NIDA NIH HHS DA14684NIDA NIH HHS R01 DA014684NIDDK NIH HHS DK085712NIDDK NIH HHS R01 DK085712
6 · The paper itself

Abstract

Across species, the brain evolved to respond to natural rewards such as food and sex. These physiological responses are important for survival, reproduction and evolutionary processes. It is no surprise, therefore, that many of the neural circuits and signaling pathways supporting reward processes are conserved from Caenorhabditis elegans to Drosophilae, to rats, monkeys and humans. The central role of dopamine (DA) in encoding reward and in attaching salience to external environmental cues is well recognized. Less widely recognized is the role of reporters of the "internal environment", particularly insulin, in the modulation of reward. Insulin has traditionally been considered an important signaling molecule in regulating energy homeostasis and feeding behavior rather than a major component of neural reward circuits. However, research over recent decades has revealed that DA and insulin systems do not operate in isolation from each other, but instead, work together to orchestrate both the motivation to engage in consummatory behavior and to calibrate the associated level of reward. Insulin signaling has been found to regulate DA neurotransmission and to affect the ability of drugs that target the DA system to exert their neurochemical and behavioral effects. Given that many abused drugs target the DA system, the elucidation of how dopaminergic, as well as other brain reward systems, are regulated by insulin will create opportunities to develop therapies for drug and potentially food addiction. Moreover, a more complete understanding of the relationship between DA neurotransmission and insulin may help to uncover etiological bases for "food addiction" and the growing epidemic of obesity. This review focuses on the role of insulin signaling in regulating DA homeostasis and DA signaling, and the potential impact of impaired insulin signaling in obesity and psychostimulant abuse.

Indexed as

Signal TransductionAnimalsBehavior, AddictiveBrainDopamineHumansInsulinInsulin ResistanceNeuronsObesityReceptor, InsulinDopamineInsulinReceptor, Insulin

Identifiers

PMID21420985
PMCPMC3518862
OpenAlexW2129106194

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.